Alterations in mitochondria isolated from peripheral blood mononuclear cells and tumors of patients with epithelial ovarian cancers

被引:1
作者
Charoenkwan, Kittipat [1 ]
Apaijai, Nattayaporn [2 ,3 ,4 ]
Sriwichaiin, Sirawit [2 ,3 ,4 ]
Chattipakorn, Nipon [2 ,3 ,4 ]
Chattipakorn, Siriporn C. [2 ,3 ,5 ]
机构
[1] Chiang Mai Univ, Fac Med, Dept Obstet & Gynecol, Div Gynecol Oncol, Chiang Mai 50200, Thailand
[2] Chiang Mai Univ, Fac Med, Cardiac Electrophysiol Res & Training Ctr, Neurophysiol Unit, Chiang Mai 50200, Thailand
[3] Chiang Mai Univ, Ctr Excellence Cardiac Electrophysiol Res, Chiang Mai 50200, Thailand
[4] Chiang Mai Univ, Fac Med, Dept Physiol, Cardiac Electrophysiol Unit, Chiang Mai 50200, Thailand
[5] Chiang Mai Univ, Fac Dent, Dept Oral Biol & Diagnost Sci, Chiang Mai 50200, Thailand
关键词
P53-INDUCIBLE REGULATOR; CHEMORESISTANCE; METABOLISM; P53;
D O I
10.1038/s41598-023-51009-z
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Metabolic alterations play an essential role in ovarian carcinogenesis. The flexibility of mitochondrial functions facilitates cellular adaptation to the tough environment associated with carcinogenesis. An understanding of the differences in mitochondrial functions in normal ovaries and cancers could provide a basis for further exploration of future mitochondria-based screening, diagnosis, prognostic prediction, and targeted therapy for epithelial ovarian cancers. The main objective of this study was to assess mitochondrial function profiles measured from PBMCs and ovarian tissues of epithelial ovarian cancers in comparison with normal ovaries. A total of 36 patients were recruited for the study, all of whom underwent primary surgical treatment for malignant epithelial ovarian neoplasm. Of these, 20 patients were in the early stage and 16 patients were in the advanced stage. Additionally, 21 patients who had pelvic surgery for benign gynecologic conditions, with normal ovaries incidentally removed, were recruited as controls. At the time of surgery, a blood sample was collected from each participant for PBMC isolation, and ovarian tissue was retained for molecular studies. These studies included the examination of oxidative stress, mitochondrial mass, mitochondrial respiration, mitochondrial reactive oxygen species (ROS), mitochondrial membrane potential (MMP) changes, and mitochondrial swelling. Clinical and histopathological data were also collected and compared between different stages of epithelial ovarian cancers: early-stage (group 1), advanced-stage (group 2), and normal ovaries (group 3). The levels of cellular oxidative stress, mitochondrial mass, and mitochondrial biogenesis in the peripheral blood mononuclear cells (PBMCs) of participants with ovarian cancer were significantly lower than those of the control group. However, the mitochondrial respiratory parameters measured from the PBMCs were similar across all three groups. Furthermore, mitochondrial membrane depolarization and mitochondrial swelling were observed in ovarian tissues of both early-stage and advanced-stage cancer groups. We demonstrated the dynamic nature of mitochondrial ROS production, biogenesis, and respiratory function in response to epithelial ovarian carcinogenesis. The flexibility of mitochondrial functions under diverse conditions may make it a challenging therapeutic target for ovarian cancer.
引用
收藏
页数:9
相关论文
共 30 条
[1]   Mitochondrial Dynamics - Mitochondrial Fission and Fusion in Human Diseases [J].
Archer, Stephen L. .
NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (23) :2236-2251
[2]   Mitochondrial Dysfunction in Cancer and Neurodegenerative Diseases: Spotlight on Fatty Acid Oxidation and Lipoperoxidation Products [J].
Barrera, Giuseppina ;
Gentile, Fabrizio ;
Pizzimenti, Stefania ;
Canuto, Rosa Angela ;
Daga, Martina ;
Arcaro, Alessia ;
Cetrangolo, Giovanni Paolo ;
Lepore, Alessio ;
Ferretti, Carlo ;
Dianzani, Chiara ;
Muzio, Giuliana .
ANTIOXIDANTS, 2016, 5 (01)
[3]   TIGAR, a p53-inducible regulator of glycolysis and apoptosis [J].
Bensaad, Karim ;
Tsuruta, Atsushi ;
Selak, Mary A. ;
Calvo Vidal, M. Nieves ;
Nakano, Katsunori ;
Bartrons, Ramon ;
Gottlieb, Eyal ;
Vousden, Karen H. .
CELL, 2006, 126 (01) :107-120
[4]   Mitochondrial dysfunction in cancer [J].
Boland, Michelle L. ;
Chourasia, Aparajita H. ;
Macleod, Kay F. .
FRONTIERS IN ONCOLOGY, 2013, 3
[5]   Mitochondria-targeted drug delivery in cancers [J].
Cho, Hana ;
Cho, Yong-Yeon ;
Shim, Min Suk ;
Lee, Joo Young ;
Lee, Hye Suk ;
Kang, Han Chang .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2020, 1866 (08)
[6]  
Flemming G., 2013, Principles and Practice of Gynecologic Oncology, V6th, P757
[7]   p53, a novel regulator of lipid metabolism pathways [J].
Goldstein, Ido ;
Ezra, Osnat ;
Rivlin, Noa ;
Molchadsky, Alina ;
Madar, Shalom ;
Goldfinger, Naomi ;
Rotter, Varda .
JOURNAL OF HEPATOLOGY, 2012, 56 (03) :656-662
[8]   Oxidative stress, mitochondrial damage and neurodegenerative diseases [J].
Guo, Chunyan ;
Sun, Li ;
Chen, Xueping ;
Zhang, Danshen .
NEURAL REGENERATION RESEARCH, 2013, 8 (21) :2003-2014
[9]   Does TP53 mutation promote ovarian cancer metastasis to omentum by regulating lipid metabolism? [J].
Hu, Jing ;
Liu, Zhiqiang ;
Wang, Xipeng .
MEDICAL HYPOTHESES, 2013, 81 (04) :515-520
[10]  
implications for therapeutic intervention in cancer, 2022, Cell. Biol. Toxicol, V38, P377, DOI [10.1007/s10565-021-09662-5, DOI 10.1007/S10565-021-09662-5]